2 February 2021
2 min read
Training the next generation of translational scientists
The i2TRON PhD Training Programme kicks off
On February 1st, the new i2TRON (Integrating immune strategies for Translational Research in Oncology and Neurology) research and training programme for PhD candidates officially started. Its overarching goal is to develop the ability of doctoral candidates to successfully translate fundamental research findings into innovative pre-clinical and clinical applications, thereby contributing to shaping the next generation of translational researchers and to developing advanced medicine and care.
says Prof Rejko Krüger, Director of Transversal Translational Medicine (TTM) at LIH and coordinator of i2TRON.
“This is an entirely new concept for Luxembourg, which also paves the way for a joint programme of students from life sciences and medicine, thereby fostering the emergence of so-called ‘clinician-scientists’. This innovative and highly interdisciplinary profile effectively combines the knowledge and skills of a translational research path with those of a medical career, thereby contributing to bridging the gap between fundamental research and clinical practice through a multidisciplinary approach”
Additionally, the programme benefits from the expertise of Prof Simone Niclou, Director of the LIH Department of Oncology, and Prof Markus Ollert, Director of the LIH Department of Infection and Immunity, who act as co-coordinators. In parallel, Dr Iris Egner, Project Manager within TTM, ensures the smooth administrative management of the programme.
i2TRON is financially supported by the Luxembourg National Research Fund (FNR) through the competitive PRIDE programme.